| # | Drug | Count |
|---|---|---|
| 0 | AXICABTAGENE CILOLEUCEL | 76 |
| 1 | CYCLOPHOSPHAMIDE | 69 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 69 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 69 |
| 4 | FLUDARABINE PHOSPHATE | 69 |
| 5 | ZANUBRUTINIB | 56 |
| 6 | GADOBUTROL | 14 |
| 7 | HUMAN IMMUNOGLOBULIN G | 14 |
| 8 | NIVOLUMAB | 7 |
| 9 | CARBOPLATIN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZANUBRUTINIB | 56 | 0.0123 |
| 1 | AXICABTAGENE CILOLEUCEL | 76 | 0.0075 |
| 2 | GADOBUTROL | 14 | 0.0029 |
| 3 | MILTEFOSINE | 1 | 0.0026 |
| 4 | FLUDARABINE PHOSPHATE | 69 | 0.0017 |
| 5 | CYCLOSERINE | 3 | 0.0013 |
| 6 | LAROTRECTINIB | 1 | 0.0011 |
| 7 | PENTAMIDINE ISETHIONATE | 1 | 0.0008 |
| 8 | GADOBENATE DIMEGLUMINE | 3 | 0.0007 |
| 9 | HUMAN IMMUNOGLOBULIN G | 14 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Chimeric Antigen Receptor [EPC] | 76 | 0.0075 |
| 1 | Gadolinium-based Contrast Agent [EPC] | 14 | 0.0029 |
| 2 | Antileishmanial [EPC] | 1 | 0.0026 |
| 3 | Human Immunoglobulin G [EPC] | 14 | 0.0007 |
| 4 | Paramagnetic Contrast Agent [EPC] | 2 | 0.0004 |
| 5 | Alkylating Drug [EPC] | 70 | 0.0003 |
| 6 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 7 | Antimycobacterial [EPC] | 3 | 0.0001 |
| 8 | Vitamin K [EPC] | 1 | 0.0001 |
| 9 | Nuclear Export Inhibitor [EPC] | 1 | 0.0001 |